1 week Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study DataZacks
NVAX and RNA are in the spotlight following Q3 results and study data, respectively.
XNVAX and RNA are in the spotlight following Q3 results and study data, respectively.
X